Adrenocortical insufficiency in a critically-ill patient;Insuficiencia corticosuprarrenal en el paciente crítico

Medicina Intensiva

Volumn 28, Issue 4, 2004, Pages 208-210

  Lopez Martinez J ^a   Suarez Saiz J ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; CRITICAL ILLNESS; HEMODYNAMICS; HYPOPHYSIS ADRENAL SYSTEM; INTENSIVE CARE; SEPTIC SHOCK; SHORT SURVEY;

EID: 2642575683     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5691(04)70047-9     Document Type: Short Survey

References (20)

1. Weitzman S, Berger S. Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 1974;81:36-42.
2. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976;184:333-41.
3. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis: the Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987;317:659-65.
4. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
5. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
6. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
7. Bollaert PE, Charpentier C, Lewy B, Debouverie M, Audibert G, Larcan A. Reversal of septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-50.
8. Meduri GU, Headley AS, Golden EM, Carson SJ, Umberger RA, Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-65.
9. Briegel J, Forst H, Haller M, Achelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-32.
10. Sessler CN. Steroids for septic shock. Back from the dead? (Cont). Chest 2003;123(Suppl):S482-9.
11. Balk RA. Steroids for septic shock. Back from the dead? (Pro). Chest 2003;123(Suppl):S490-9
12. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
13. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-34.
14. Riché F, Laisné MJ, Alvers A. Corticosteroid insufficiency in acutely ill patients. To the editor. N Engl J Med 2003;348:2158-9.
15. Oelkers W. Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin test. Eur J Endocrinol 1996;135:27-33.
16. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001;17:25-41.
17. Manglik S, Flores E, Lubarsky L, Fernández F, Chhibber VL, Tayek JA. Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial. Crit Care Med 2003;31:1668-75.
18. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003;31:141-5.
19. Casares Vivas M, Raurich Puigdevall JM, Ayestanin Rota I, Llompart Santamaría E, Ibáñez Juvé J. Shock séptico e insuficiencia suprarrenal relativa. Med Intensiva 2003;27:525-30.
20. Annane D. Time for a consensus definition of corticosteroid insufficiency in critically ill patients. Crit Care Med 2003;31:1868-9.